Next Article in Journal
Susceptibility Tests and Predictions of Transporter Profile in Serratia Species
Next Article in Special Issue
Leishmania Vesicle-Depleted Exoproteome: What, Why, and How?
Previous Article in Journal
Immunomodulatory Effects of Probiotics: A Novel Preventive Approach for the Control of Bovine Mastitis
Previous Article in Special Issue
Use of Antigen Combinations to Address Complex Leishmania-Seropositivity Patterns in Dogs Living in Canine Leishmaniosis Endemic Regions of Portugal
 
 
Communication
Peer-Review Record

Identification of Leishmania infantum Epidemiology, Drug Resistance and Pathogenicity Biomarkers with Nanopore Sequencing

Microorganisms 2022, 10(11), 2256; https://doi.org/10.3390/microorganisms10112256
by Joan Martí-Carreras 1,*,†, Marina Carrasco 1,†, Marcel Gómez-Ponce 1, Marc Noguera-Julián 1, Roser Fisa 2, Cristina Riera 2, Maria Magdalena Alcover 2, Xavier Roura 1,3, Lluís Ferrer 1,4 and Olga Francino 1,*
Microorganisms 2022, 10(11), 2256; https://doi.org/10.3390/microorganisms10112256
Submission received: 15 September 2022 / Revised: 8 November 2022 / Accepted: 9 November 2022 / Published: 14 November 2022

Round 1

Reviewer 1 Report

The manuscript entitled "Identification of Leishmania infantum epidemiological, drug resistance and pathogenicity biomarkers with nanopore sequencing" is relevant and important to the field of study. I have a few concerns outlined below that would improve the manuscript for publication:

1. Results can be better described to improve readers' understanding.

2. The quality/resolution of figure 2 is low.

3. Discussion must be improved.

4. Conclusions should be more summarized; part of the conclusion should be in the discussion item.

Author Response

Dear reviewer,

Thank you very much for your willingness to read and comment on our preliminary work. Much appreciated.

  1. Results can be better described to improve readers' understanding.
    1. English grammar was revised in this section. L311-312 were modified to improve clarity.
  2. The quality/resolution of figure 2 is low.
    1. The resolution of Figure 2 was improved. It has been replaced already in-text.
  3. Discussion must be improved.
    1. Discussion was mildly modified to improve readability. Part of conclusions was included in this section.
  4. Conclusions should be more summarized; part of the conclusion should be in the discussion item.
    1. We edited part of the conclusions, avoiding possible redundancy with the discussion section.

The authors would like to appreciate the reviewer for this consideration of our article for publication.

Reviewer 2 Report

In the communication entitled "Identification of Leishmania infantum epidemiological, drug resistance and pathogenicity biomarkers with nanopore sequencing" the authors performed a study on twenty-two genes to generate a genetic drug resistance profile against miltefosine, allopurinol, antimonials, amphotericin and paromomycin. Leishmaniasis is a zoonotic parasitic disease caused in the Mediterranean area by the protozoan Leishmania infantum. The latter is responsible for canine leishmaniasis (LCan) and visceral and cutaneous leishmaniasis in humans. The parasite is transmitted to humans and dogs through the bite of vector insects belonging to the genus Phlebotomus spp., Commonly referred to as sand flies . The dog is the main domestic reservoir for the parasite. The emergence of drug-resistant strains of the parasite Leishmania infantum infecting dogs and humans place this issue in great public health concern as they represent a growing threat.
The manuscript provides information that is included in the scope of microbilology. The communication can be published in its current form in a high-level journal such as Microorganisms.

Author Response

Dear reviewer,

We'd like to extend our joy that you found our preliminary results interesting and worthy of publication in this journal. We hope it was found useful as well in your research.

Warm regards.

Back to TopTop